scispace - formally typeset
Q

Qi Xia

Researcher at Zhejiang University

Publications -  8
Citations -  731

Qi Xia is an academic researcher from Zhejiang University. The author has contributed to research in topics: Promoter & Cancer. The author has an hindex of 4, co-authored 7 publications receiving 669 citations.

Papers
More filters
Journal ArticleDOI

A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients.

TL;DR: The findings of the present study suggest that the Chinese diagnostic criteria of ACLF might be broadened, thus enabling implementation of a novel model to predict ACLF-related death after comprehensive medical treatment.
Journal ArticleDOI

Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure

TL;DR: Downgrading MELD for liver transplant candidates with MELD score ≥30 was effective in improving patient prognosis, and an appropriate ALSS treatment within 48 h prior to LT is potentially beneficial.
Journal ArticleDOI

Relationship between TNF- gene promoter polymorphisms and outcomes of hepatitis B virus infections: a meta-analysis.

TL;DR: The data showed that polymorphisms -863 A and -308 G in the TNF- gene promoter region might be risk factors for HBV persistence and ethnicity might play an important role in HBV infection outcome, leading to conflicting results.
Journal ArticleDOI

Clinical efficacy of Methylprednisolone and the combined use of Lopinavir/Ritonavir with Arbidol in treatment of Coronavirus Disease 2019.

TL;DR: In this article, the therapeutic efficacy of multiple medication plans over Lopinavir/Ritonavir (LPV/r), Arbidol (ARB) and Methylprednisolone on patients with Coronavirus Disease 2019 (COVID-19) was analyzed.